The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis

The macrophage activation marker soluble (s)CD163 is associated with disease severity and prognosis in patients with primary biliary cholangitis (PBC). Ursodeoxycholic acid (UDCA) treatment attenuates fibrosis progression in PBC patients, but its effect on macrophage activation is unclear. We examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossen, Lars, Lau, Tobias Stemann, Nielsen, Mette Bak, Nielsen, Marlene Christina, Andersen, Astrid Højmark, Ott, Peter, Becker, Sabine, Glerup, Henning, Svenningsen, Lise, Eivindson, Martin, Kornerup, Linda, Kjeldsen, Niels Bjørndal, Neumann, Anders, Møller, Holger Jon, Jepsen, Peter, Grønbæk, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043550/
https://www.ncbi.nlm.nih.gov/pubmed/36972379
http://dx.doi.org/10.1097/HC9.0000000000000068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043550/
https://www.ncbi.nlm.nih.gov/pubmed/36972379
http://dx.doi.org/10.1097/HC9.0000000000000068

Ejemplares similares